CA3294847A1 - Formulations de protéines chimériques à base de clec9a - Google Patents

Formulations de protéines chimériques à base de clec9a

Info

Publication number
CA3294847A1
CA3294847A1 CA3294847A CA3294847A CA3294847A1 CA 3294847 A1 CA3294847 A1 CA 3294847A1 CA 3294847 A CA3294847 A CA 3294847A CA 3294847 A CA3294847 A CA 3294847A CA 3294847 A1 CA3294847 A1 CA 3294847A1
Authority
CA
Canada
Prior art keywords
clec9a
chimeric protein
protein formulations
based chimeric
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3294847A
Other languages
English (en)
Inventor
Nikolai Kley
Erik Depla
Dorien VAN LYSEBETTEN
Original Assignee
Orionis Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orionis Biosciences Inc filed Critical Orionis Biosciences Inc
Publication of CA3294847A1 publication Critical patent/CA3294847A1/fr
Pending legal-status Critical Current

Links

CA3294847A 2023-06-09 2024-06-07 Formulations de protéines chimériques à base de clec9a Pending CA3294847A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/507,263 2023-06-09

Publications (1)

Publication Number Publication Date
CA3294847A1 true CA3294847A1 (fr) 2024-12-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP4084629A4 (fr) Compositions alimentaires à haute teneur en protéines
EP4041283A4 (fr) Protéines chimériques d'il-2 pour immunosuppression
EP3914702A4 (fr) Constructions de fusion de régulation de fonction protéique
EP4210757A4 (fr) Composés excipients pour formulations de protéines
AU2023409934A1 (en) Artificial protein compositions
CA3294847A1 (fr) Formulations de protéines chimériques à base de clec9a
CA3262152A1 (fr) Formulations d'anticorps anti-tl1a
AU2024298172A1 (en) Chimeric protein vaccine
CA3299610A1 (fr) Vaccin protéique chimérique
AU2023902373A0 (en) Chimeric protein vaccine
EP4034146A4 (fr) Protéines chimériques conjuguées
CA3262504A1 (fr) Formulation protéiques
HK40129881A (zh) 贝祖拉替尼制剂
AU2021903589A0 (en) Protein compositions
HK40115923A (en) Enhanced protein compositions
CA3277614A1 (fr) Formulations de bezuclastinib
AU2023903711A0 (en) Formulations
HK40111642A (en) Interleukin-1 alpha chimeric protein
HK40125981A (en) Anti-tl1a antibody formulations
CA3269753A1 (fr) Formulations pour anticorps anti-c1q
CA3294652A1 (fr) Nouvelles formulations
AU2024307383A1 (en) Novel formulations
HK40129331A (en) Cd40-binding proteins
CA3282687A1 (fr) Protéines de liaison au cd40
HK40119775A (en) Chimeric polypeptides